EUDA Health (EUDA) vs Strata Critical Medical (SRTA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Strata Critical Medical (SRTA) has outperformed EUDA Health (EUDA) over the past year, gaining 8.6% versus a loss of 71.8%. Strata Critical Medical is the larger company by market cap ($407.3 million vs $47.8 million), about 8.5 times the size, while EUDA Health is growing revenue faster (+70.0% vs +34.3%). Strata Critical Medical converts more of its revenue into profit, with a net margin of 21.0% versus -40.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EUDA | SRTA |
|---|---|---|
| Share price | $15.96 | $4.56 |
| Market cap | $47.79M | $407.30M |
| 1-day change | -7.69% | -5.59% |
| YTD return | -65.45% | -5.20% |
| 1-year return | -71.80% | +8.57% |
| 5-year return | — | -46.79% |
| Forward P/E | 9.97 | — |
| EPS (TTM) | $-1.18 | $-0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $6.82M | $197.14M |
| Revenue growth (YoY) | +70.04% | +34.28% |
| Net income (latest FY) | $-2.77M | $41.35M |
| Gross margin | 43.88% | 20.86% |
| Operating margin | -36.33% | -11.34% |
| Net margin | -40.65% | 20.97% |
| 52-week high | $68.00 | $6.50 |
| 52-week low | $5.26 | $3.95 |
| Distance from 52-week high | -76.53% | -29.85% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +244.61% | +111.18% |
| Average volume | 37.77K | 982.75K |
| Shares outstanding | 2.99M | 89.32M |
| Employees | 123 | 327 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Strata Critical Medical is about 8.5 times larger than EUDA Health by market value ($407.30M vs $47.79M).
- SRTA has outperformed EUDA by 80.4 percentage points over the past year.
- Strata Critical Medical is more profitable, keeping 21.0 cents of every revenue dollar as net income versus -40.7 cents for EUDA Health.
- EUDA Health grew revenue faster in its latest fiscal year (+70.04% vs +34.28%).
About EUDA Health
EUDA stock →EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services.
Health Care · Medical/Nursing Services · 123 employees
About Strata Critical Medical
SRTA stock →Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States.
Health Care · Medical/Nursing Services · 327 employees
EUDA vs SRTA FAQ
Which is bigger, EUDA Health or Strata Critical Medical?
Strata Critical Medical (SRTA) is larger, with a market capitalization of $407.30M compared with $47.79M for EUDA Health (EUDA).
Which stock has performed better over the past year, EUDA or SRTA?
SRTA returned +8.57% over the past 12 months, compared with -71.80% for EUDA (price return, excluding dividends). Past performance does not predict future results.
Are EUDA Health and Strata Critical Medical in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.